UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm

European journal of clinical investigation, 2020-03, Vol.50 (3), p.e13209-n/a

2020

Volltextzugriff (PDF)

Bloodstream infections in critically ill patients: an expert statement

Intensive care medicine, 2020-02, Vol.46 (2), p.266-284

2020

Volltextzugriff (PDF)

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper

Intensive care medicine, 2020-06, Vol.46 (6), p.1127-1153

2020

Volltextzugriff (PDF)

How to manage Pseudomonas aeruginosa infections

Drugs in Context, 2018, Vol.7, p.212527-18

2018

Volltextzugriff (PDF)

Post-operative abdominal infections: epidemiology, operational definitions, and outcomes

Intensive care medicine, 2020-02, Vol.46 (2), p.163-172

2020

Volltextzugriff (PDF)

New antibiotics for bad bugs: where are we?

Annals of clinical microbiology and antimicrobials, 2013-08, Vol.12 (1), p.22-22

2013

Volltextzugriff (PDF)

The management of multidrug-resistant Enterobacteriaceae

Current opinion in infectious diseases, 2016-12, Vol.29 (6), p.583-594

2016

Volltextzugriff (PDF)

Treatment of Infections Due to MDR Gram-Negative Bacteria

Frontiers in medicine, 2019-04, Vol.6, p.74-74

2019

Volltextzugriff (PDF)

Bacterial and fungal superinfections in critically ill patients with COVID-19

Intensive care medicine, 2020-11, Vol.46 (11), p.2071-2074

2020

Volltextzugriff (PDF)

Therapeutic Potential of the Gut Microbiota in the Management of Sepsis

Critical care (London, England), 2020-03, Vol.24 (1), p.105-105, Article 105

2020

Volltextzugriff (PDF)

How to manage KPC infections

Therapeutic Advances in Infectious Disease, 2020, Vol.7

2020

Volltextzugriff (PDF)

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae

Critical care (London, England), 2020-01, Vol.24 (1), p.29-29, Article 29

2020

Volltextzugriff (PDF)

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

The Lancet infectious diseases, 2021-06, Vol.21 (6), p.e149-e162

2021

Volltextzugriff (PDF)

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?

Intensive care medicine, 2021-01, Vol.47 (1), p.104-106

2021

Volltextzugriff (PDF)

Distinct phenotypes require distinct respiratory management strategies in severe COVID-19

Respiratory physiology & neurobiology, 2020-08, Vol.279, p.103455-103455, Article 103455

2020

Volltextzugriff (PDF)

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

Journal of antimicrobial chemotherapy, 2015-07, Vol.70 (7), p.2133-2143

2015

Volltextzugriff (PDF)

Rationalizing antimicrobial therapy in the ICU: a narrative review

Intensive care medicine, 2019-02, Vol.45 (2), p.172-189

2019

Volltextzugriff (PDF)

Timing of antibiotic therapy in the ICU

Critical care (London, England), 2021-10, Vol.25 (1), p.360-360, Article 360

2021

Volltextzugriff (PDF)

The global challenge of Candida auris in the intensive care unit

Critical care (London, England), 2019-05, Vol.23 (1), p.150-150, Article 150

2019

Volltextzugriff (PDF)

Eravacycline for the treatment of intra-abdominal infections

Expert opinion on investigational drugs, 2014-11, Vol.23 (11), p.1575-1584

2014

Volltextzugriff (PDF)

ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

Intensive care medicine, 2019-06, Vol.45 (6), p.789-805

2019

Volltextzugriff (PDF)

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

PloS one, 2011-09, Vol.6 (9), p.e24198-e24198

2011

Volltextzugriff (PDF)

Development of novel antibacterial drugs to combat multiple resistant organisms

Langenbeck's archives of surgery, 2015-02, Vol.400 (2), p.153-165

2015

Volltextzugriff (PDF)

Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU

Intensive care medicine, 2020-05, Vol.46 (5), p.1039-1042

2020

Volltextzugriff (PDF)

1 – 25 von 847

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(761)
Mit Volltextzugriff
(683)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(656)
Life Sciences & Biomedicine
(642)
Humans
(429)
Infectious Diseases
(342)
Microbiology
(188)
Pharmacology & Pharmacy
(187)
Male
(176)
Female
(156)
General & Internal Medicine
(148)
Anti-Bacterial Agents - Therapeutic Use
(137)
Middle Aged
(128)
Medicine
(119)
Covid-19
(117)
Mortality
(115)
Antibiotics
(113)
Aged
(112)
Medicine & Public Health
(108)
Critical Care Medicine
(105)
Infections
(104)
Adult
(103)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm

Bloodstream infections in critically ill patients: an expert statement

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper

How to manage Pseudomonas aeruginosa infections

Post-operative abdominal infections: epidemiology, operational definitions, and outcomes

New antibiotics for bad bugs: where are we?

The management of multidrug-resistant Enterobacteriaceae

Treatment of Infections Due to MDR Gram-Negative Bacteria

Bacterial and fungal superinfections in critically ill patients with COVID-19

Therapeutic Potential of the Gut Microbiota in the Management of Sepsis

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

How to manage KPC infections

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?

Distinct phenotypes require distinct respiratory management strategies in severe COVID-19

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

Rationalizing antimicrobial therapy in the ICU: a narrative review

Timing of antibiotic therapy in the ICU

The global challenge of Candida auris in the intensive care unit

Eravacycline for the treatment of intra-abdominal infections

ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

Development of novel antibacterial drugs to combat multiple resistant organisms

Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU

Suchergebnisse filtern